Parthenon Capital invests in Momentum Life Sciences

Parthenon Capital has made an investment in Momentum Life Sciences, an Indianapolis-based provider of patient support solutions, according to PE Hub. The report did not include a transaction value, ownership percentage or financing details.

PE Hub said the investment is intended to give Momentum strategic resources and capital to advance its growth plan and pursue acquisitions. For investors and operators, the transaction adds private equity backing to a healthcare services company whose business is tied to patient support, an area where scale and operational execution can shape growth strategy.

Momentum’s current leadership team will remain significant shareholders after the investment, PE Hub reported. That structure indicates continuing management participation alongside the new financial sponsor, though PE Hub did not state whether Parthenon acquired a controlling or minority position.

Andi Heslin Smiley serves as president and chief executive of Momentum Life Sciences, according to PE Hub. No changes to executive leadership were reported.

Capital for growth and acquisitions

The reported use of proceeds is twofold: support Momentum’s broader growth strategy and fund strategic acquisitions. In private equity-backed healthcare services deals, sponsor capital can be used to support internal expansion, add operating resources and finance purchases of complementary businesses. PE Hub did not identify any acquisition targets or specify a timetable.

The continued shareholding by Momentum’s existing leadership is a relevant feature of the transaction. Management rollover stakes are commonly used to keep senior executives economically aligned with a new sponsor after an investment. In this case, PE Hub reported only that the leadership team will continue as significant shareholders, without disclosing the size or terms of those holdings.

Parthenon Capital is the private equity investor in the deal, according to PE Hub. Momentum Life Sciences is based in Indianapolis and provides patient support solutions. Further details on the company’s customers, revenue, workforce and geographic reach were not included in the report.

The transaction comes amid continued private equity interest in healthcare services businesses, although PE Hub’s report did not provide valuation metrics or market comparisons for this deal. Without disclosed financial terms, the immediate market impact is limited to the parties involved and to potential acquisition activity by Momentum following the investment.

This story draws on original reporting from PE Hub.